Zions Bancorporation’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-292
Closed -$48K 1083
2021
Q2
$48K Sell
292
-1
-0.3% -$167 ﹤0.01% 434
2021
Q1
$45K Hold
293
0.01% 440
2020
Q4
$37K Sell
293
-78
-21% -$8.72K ﹤0.01% 446
2020
Q3
$38K Buy
371
+78
+27% +$7.95K 0.01% 427
2020
Q2
$29K Hold
293
﹤0.01% 422
2020
Q1
$24K Buy
293
+103
+54% +$10K ﹤0.01% 425
2019
Q4
$21K Hold
190
﹤0.01% 600
2019
Q3
$19K Hold
190
﹤0.01% 598
2019
Q2
$19K Sell
190
-385
-67% -$36.7K ﹤0.01% 561
2019
Q1
$63K Hold
575
0.01% 371
2018
Q4
$53K Hold
575
0.04% 164
2018
Q3
$63K Hold
575
0.02% 295
2018
Q2
$54K Hold
575
0.04% 168
2018
Q1
$48K Buy
+575
New +$51.1K 0.01% 270
2017
Q4
Sell
-634
Closed -$48K 1031
2017
Q3
$48K Buy
+634
New +$47.9K 0.01% 580

Other funds holding PRAH

Zions Bancorporation's PRAH Position: Q3 2021 in Review

Zions Bancorporation sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 292 shares — an estimated $48K sold.

Zions Bancorporation first reported a position in PRAH in Q3 2017 and held it in 15 quarters. The position peaked at $63K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Zions Bancorporation reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Zions Bancorporation sold 292 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $48K.
  • Zions Bancorporation first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 15 quarters.
  • Zions Bancorporation's PRA Health Sciences, Inc. position peaked at $63K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Zions Bancorporation's 13F filing for Q3 2021, filed 10 Nov 2021.